ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

LIPO Lipella Pharmaceuticals Inc

0.6419
0.0166 (2.65%)
May 31 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Lipella Pharmaceuticals Inc LIPO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0166 2.65% 0.6419 16:58:11
Open Price Low Price High Price Close Price Previous Close
0.61 0.61 0.662 0.6419 0.6253
more quote information »

Recent News

Date Time Source Heading
5/31/202407:00GLOBELipella Pharmaceuticals Announces Completion of Site..
5/29/202407:00GLOBELipella Pharmaceuticals Announces Abstract Publication at..
5/21/202407:00GLOBEFollowing Guidance from U.S. Food & Drug Administration in..
5/15/202415:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/09/202415:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/06/202415:05EDGAR2Form SC 13D/A - General statement of acquisition of..
4/17/202407:00GLOBELipella Pharmaceuticals Expands its Advisory Board to..
4/05/202407:00GLOBELipella Pharmaceuticals to Publish Abstract Detailing..
4/03/202407:00GLOBELipella Pharmaceuticals Announces FDA Type C Meeting for..
3/07/202414:23GLOBEPRISM MarketView Spotlights Lipella Pharmaceuticals as it..
3/06/202416:05EDGAR2Form SC 13D/A - General statement of acquisition of..
3/06/202416:03EDGAR2Form SC 13D/A - General statement of acquisition of..
3/05/202407:00GLOBELipella Pharmaceuticals Announces FDA Clearance of IND for..
2/27/202416:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2/27/202415:51EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/20/202407:00GLOBELipella Pharmaceuticals to Present at PropThink Digital..
2/08/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/07/202416:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202415:09EDGAR2Form S-3 - Registration statement under Securities Act of..
1/25/202415:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/03/202415:59EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/20/202307:00GLOBELipella Pharmaceuticals Marks Successful First Year with..
11/28/202316:28EDGAR2Form 8-K - Current report
11/22/202315:05EDGAR2Form 8-K - Current report
11/14/202305:22EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/14/202305:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/10/202307:00PRNUSFDA Grants Orphan Designation for Lipella's LP-310 Drug..
11/09/202315:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/01/202315:06EDGAR2Form S-1 - General form for registration of securities under..
10/25/202315:05PRNUSLipella Pharmaceuticals Announces Closing of $2 Million..
10/24/202307:00PRNUSLipella Pharmaceuticals Announces $2 Million Private..
10/20/202307:00PRNUSLipella Pharmaceuticals Announces FDA Clearance of IND for..
10/10/202315:05EDGAR2Form DEF 14A - Other definitive proxy statements
9/21/202307:30PRNUSLipella Pharmaceuticals' Phase 2a Clinical Study Results..
9/11/202306:38EDGAR2Form 8-K - Current report
8/14/202315:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202315:30EDGAR2Form 8-K - Current report
8/02/202315:05EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock